OakChart

Bausch + Lomb Corp

BLCOHealthcare·Medical Instruments & Supplies·Canada·Mid·NYSE·Nov 11 • 3:07 PM ET

21.31-0.06 (-0.28%)
2026-11-11 21:07 CET
Market cap
7,639.71 USD m
Revenue, TTM
5,418.00 USD m
Net income, TTM
-111.00 USD m
Free cash flow, TTM
251.80 USD m
EPS diluted, TTM
-0.31
P/E
-
Compare

Price

BLCO against its 20, 50 and 200-day averages
2050200beatmiss
16.0018.0020.002.1M4.1MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26BLCOclose 21.3120-day 18.9550-day 17.86200-day 16.8121.3152w low

0.4% under the 52-week high of 21.40 on 10 Nov 2026. 52-week low 14.44 on 20 Nov 2025. Last 15 sessions, 25.8% high to low

Volume 0.67× normal · the line is the 50-bar volume average

Profile

BLCO
52-week range, 99% of the way up
14.4421.40

Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.

Employees13000
IPOMay 06, 2022
Beta0.51
ATR, 14d0.68
Rel volume0.67
Short float6.46%
Insider own88.79%
Inst own10.10%

Snapshot

6 groups

Valuation

Index-
Market Cap7.62B
Enterprise Value12.27B
Income-111.00M
Sales5.42B
Book/sh18.02
Cash/sh1.44
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees13000
IPOMay 06, 2022

Ratios

P/E-
Forward P/E17.95
PEG0.41
P/S1.41
P/B1.18
P/C14.79
P/FCF30.26
EV/EBITDA13.42
EV/Sales2.26
Quick Ratio1.04
Current Ratio1.56
Debt/Eq0.79
LT Debt/Eq0.78
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.31
EPS next Y1.19
EPS next Q0.37
EPS this Y83.70%
EPS next Y26.69%
EPS next 5Y43.70%
EPS past 3/5Y- -
Sales past 3/5Y10.62% 8.38%
EPS Y/Y TTM63.73%
Sales Y/Y TTM8.88%
EPS Q/Q212.03%
Sales Q/Q7.34%
EarningsOct 28 BMO
EPS/Sales Surpr.58.51% 0.21%

Ownership

Insider Own88.79%
Insider Trans-0.06%
Inst Own10.10%
Inst Trans-0.44%
ROA-0.80%
ROE-1.73%
ROIC-0.97%
Gross Margin58.36%
Oper. Margin9.41%
Profit Margin-2.05%
SMA2012.47%
SMA5019.32%
SMA20026.77%
Trades-

Technical

Shs Outstand357.39M
Shs Float40.09M
Short Float6.46%
Short Ratio4.16
Short Interest2.59M
52W High21.40 -0.42%
52W Low14.44 47.58%
Volatility3.65% 3.69%
ATR (14)0.68
RSI (14)74.30
Beta0.51
Rel Volume0.67
Avg Volume622.20K
Volume360,465

Performance

Perf Week3.45%
Perf Month34.79%
Perf Quarter25.50%
Perf Half Y31.14%
Perf YTD24.77%
Perf Year29.70%
Perf 3Y32.86%
Perf 5Y-
Perf 10Y-
Recom2.41
Target Price21.92
Prev Close21.37
Price21.31
Change %-0.28%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 02, 2026DowngradeHH.C. WainwrightBuy → Neutral$22+3.2%
Oct 07, 2026InitiatedBBarclaysOverweight$24+12.6%
Sep 09, 2026InitiatedLLeerink PartnersOutperform$24+12.6%
Jul 28, 2026InitiatedUUBSBuy$21-1.5%
Jan 05, 2026DowngradeEEvercore ISIOutperform → In-line$18-15.5%
Dec 11, 2025UpgradeCCitigroupNeutral → Buy$20-6.1%
Dec 02, 2025UpgradeMMorgan StanleyEqual-Weight → Overweight$21-1.5%
Oct 01, 2025InitiatedGGoldmanNeutral$16-24.9%
May 02, 2025ReiteratedHH.C. WainwrightBuy$20 → $15-29.6%
Mar 28, 2025DowngradeWWells FargoOverweight → Equal Weight$24 → $15-29.6%

Peers

Mkt cap
TickerCompanyMkt cap
ALCAlcon Inc34.88B
COOCooper Companies Inc11.97B
STAAStaar Surgical Co1.33B
GKOSGlaukos Corp14.47B
WRBYWarby Parker Inc3.84B
HROWHarrow Inc1.09B
RXSTRxSight Inc212.70M
TARSTarsus Pharmaceuticals Inc3.76B
JNJJohnson & Johnson674.48B
OCULOcular Therapeutix Inc1.47B

Insider trading

latest 14 of 20
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Bernier Nathalie D.Former DirectorNov 03 '26Proposed Sale19.8840,022795,735Nov 03 11:29 AM
Munsch FrederickSVP, Controller and CAOOct 29 '26Option Exercise17.99112,0152,015,306157,846Nov 02 05:05 PM
Munsch FrederickSVP, Controller and CAOOct 29 '26Sale20.48112,0152,294,06745,831Nov 02 05:05 PM
Munsch FrederickOfficerOct 29 '26Proposed Sale20.48112,0152,294,349Oct 29 04:25 PM
Ling KarenFormer DirectorSep 28 '26Proposed Sale16.834,50075,735Sep 28 03:10 PM
Munsch FrederickSVP, Controller and CAOAug 10 '26Sale16.7852,900887,66245,831Aug 12 07:06 PM
VON ESCHENBACH ANDREW C.DirectorAug 06 '26Sale16.5012,500206,25069,792Aug 10 08:57 PM
VON ESCHENBACH ANDREW C.DirectorAug 07 '26Sale16.586,059100,45863,733Aug 10 08:57 PM
Munsch FrederickFormer OfficerAug 10 '26Proposed Sale16.7852,900887,885Aug 10 04:58 PM
VON ESCHENBACH ANDREW C.Former DirectorAug 07 '26Proposed Sale16.586,059100,430Aug 07 05:43 PM
VON ESCHENBACH ANDREW C.Former DirectorAug 06 '26Proposed Sale16.5012,500206,193Aug 06 03:11 PM
Bailey A Robert DEVP & Chief Legal OfficerMar 06 '26Buy17.1514,600250,332231,890Mar 10 05:23 PM
Eldessouky SamEVP and CFOMar 06 '26Buy17.134,00068,520403,130Mar 10 04:34 PM
SAUNDERS BRENT LCEO and Chairman of the BoardMar 06 '26Buy17.1414,700251,958966,575Mar 10 04:32 PM

Held by

AUM
TickerCompanyAUM
MGMTBallast Small/Mid Cap ETFAUM: 166.52M
DFAXDimensional World ex U.S. Core Equity 2 ETFAUM: 12.02B
GVLUGotham 1000 Value ETFAUM: 265.07M
DFICDimensional International Core Equity 2 ETFAUM: 15.45B
GUSAGoldman Sachs MarketBeta U.S. 1000 Equity ETFAUM: 2.37B
SHRTGotham Short Strategies ETFAUM: 12.94M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-280.3400.2150.0901,3751,37214
2026Q22026-07-290.1500.154-0.0391,3941,36912
2026Q12026-04-290.0800.051-0.2001,2441,21613
2025Q42026-02-180.3200.355-0.1641,4051,38514
2025Q32025-10-290.1800.160-0.0791,2811,27814
2025Q22025-07-300.0700.062-0.1751,2781,26013
2025Q12025-04-30-0.0700.021-0.6011,1371,15013
2024Q42025-02-190.2500.230-0.0091,2971,25614
2024Q32024-10-300.1700.1570.0111,1961,17313
2024Q22024-07-310.1300.129-0.4291,2161,17114
2024Q12024-05-010.0700.070-0.4761,0991,06312
2023Q42024-02-210.2400.169-0.1541,1731,10612
2023Q32023-11-010.2200.188-0.2391,007990.6812
2023Q22023-08-020.1800.146-0.0911,035963.6910
2023Q12023-05-030.1000.135-0.257931895.812
2022Q42023-02-220.2300.223-0.003996966.9211

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY1.222--3,765-
2022FY1.0701.0660.0173,7683,740
2023FY0.7300.667-0.7424,1464,078
2024FY0.6300.583-0.9014,8604,769
2025FY0.5100.529-1.0205,1015,081
2026FY-0.937--5,500
2027FY-1.187--5,825
2028FY-1.513--6,144
2029FY-2.000--6,531
2030FY-2.630--7,078

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-10-3013101,4871,4681,501
2026Q4S2026-10-2813101,4871,4681,501
2026Q4S2026-10-1413011,4831,4661,502
2026Q4S2026-10-1213021,4831,4661,502
2026Q4S2026-10-0713031,4831,4661,502
2026Q4S2026-10-0513031,4841,4661,502
2026Q4S2026-09-2113021,4861,4741,502
2026Q4S2026-09-0813021,4861,4741,502
2026Q4S2026-09-0312021,4851,4741,502
2026Q4S2026-07-3112021,4851,4741,502
2026Q4S2026-07-2912011,4871,4741,502
2026Q4S2026-07-2712001,4921,4651,498
2026Q4S2026-07-1711001,4921,4651,498
2026Q4S2026-07-1411001,4931,4721,498

Estimate history

EPS, annual----0.017-0.742-0.901-1.018-0.3142
Period20182019202020212022202320242025TTM
EPS, quarterly0.011-0.009-0.601-0.175-0.079-0.164-0.2-0.0390.089
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual366537783412376537684146479151015418
Period20182019202020212022202320242025TTM
Sales, quarterly119612801137127812811405124413941375
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual---350350.001350.914350.914354.209357.385
Period20182019202020212022202320242025MRQ
Shares, quarterly352.077350.914353.365353.804354.088354.209356.397357.057357.385
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue5,418.005,101.004,791.004,146.003,768.003,765.003,412.003,778.003,665.00
Cost of Goods Sold Incl. D&A2,256.002,308.002,160.001,882.001,763.001,759.001,608.001,675.001,690.00
Gross Profit3,162.002,793.002,631.002,264.002,005.002,006.001,804.002,103.001,975.00
Selling, General and Administrative Excl. Other2,652.002,605.002,425.002,060.001,785.001,660.001,506.001,640.001,548.00
Research and Development400.00371.00343.00324.00307.00271.00253.00258.00221.00
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income510.00188.00206.00204.00220.00346.00298.00463.00427.00
Interest Expense390.00431.00412.00296.00146.000.000.000.000.00
Unusual Expense147.00102.0061.00102.007.0029.0010.0069.0023.00
Net Income Before Taxes-4.00-317.00-234.00-166.0073.00318.00290.00399.00417.00
Income Taxes99.0035.0071.0082.0058.00125.00307.0096.00-302.00
Consolidated Net Income-103.00-352.00-305.00-248.0015.00193.00-17.00303.00719.00
Net Income From Continuing Operations-111.00-360.00-317.00-260.006.00182.00-18.00298.00710.00
Net Income-111.00-360.00-317.00-260.006.00182.00-18.00298.00710.00
EPS (Recurring)-0.02-0.82-0.78-0.540.03----
EPS (Basic, Before Extraordinaries)-0.31-1.02-0.90-0.740.02----
EPS (Diluted)-0.31-1.02-0.90-0.740.02----
EBITDA914.00609.00642.00586.00599.00761.00740.00932.00922.00
Non-Operating Income (Expense)23.0028.0033.0028.006.001.002.005.0013.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense136.67117.7172.6858.4644.2445.2636.5036.5031.39
Price To Sales Ratio1.131.191.331.441.44----
Gross Margin58.3654.7554.9254.6153.2153.2852.8755.6653.89
Operating Margin9.413.694.304.925.849.198.7312.2611.65
Net Margin-2.05-7.06-6.62-6.270.164.83-0.537.8919.37
Shares Outstanding357.39354.21350.91350.91350.00350.00---
Market Capitalization7,639.717,639.716,360.085,985.075,428.525,428.52---

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue1,375.001,394.001,244.001,405.001,281.001,278.001,137.001,280.00
Cost of Goods Sold Incl. D&A543.00584.00540.00589.00578.00592.00549.00569.00
Gross Profit832.00810.00704.00816.00703.00686.00588.00711.00
Selling, General and Administrative Excl. Other647.00702.00645.00658.00623.00675.00649.00599.00
Research and Development91.00114.00101.0094.0095.0096.0086.0093.00
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income185.00108.0059.00158.0080.0011.00-61.00112.00
Interest Expense96.0094.00100.00100.00103.00131.0097.0098.00
Unusual Expense34.0030.0033.0050.00-9.0033.0028.0030.00
Net Income Before Taxes58.00-11.00-64.0013.00-3.00-147.00-180.00-10.00
Income Taxes23.00-1.006.0071.0022.00-89.0031.00-8.00
Consolidated Net Income35.00-10.00-70.00-58.00-25.00-58.00-211.00-2.00
Net Income From Continuing Operations32.00-14.00-71.00-58.00-28.00-62.00-212.00-3.00
Net Income32.00-14.00-71.00-58.00-28.00-62.00-212.00-3.00
EPS (Recurring)0.150.02-0.13-0.06-0.10-0.11-0.550.05
EPS (Basic, Before Extraordinaries)0.09-0.04-0.20-0.16-0.08-0.18-0.60-0.01
EPS (Diluted)0.09-0.04-0.20-0.16-0.08-0.18-0.60-0.01
EBITDA287.00210.00160.00257.00189.00118.0045.00218.00
Non-Operating Income (Expense)3.005.0010.005.0011.006.006.006.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense29.2330.0226.8650.5621.3323.7022.1221.33
Price To Sales Ratio1.131.111.081.191.070.941.061.33
Gross Margin60.5158.1156.5958.0854.8853.6851.7255.55
Operating Margin13.457.754.7411.256.250.86-5.368.75
Net Margin2.33-1.00-5.71-4.13-2.19-4.85-18.65-0.23
Shares Outstanding357.39357.06356.40354.21354.09353.80353.36350.91
Market Capitalization7,639.715,904.245,633.666,049.575,332.764,597.695,110.836,360.08

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Cash & Short Term Investments397.00316.00334.00380.00177.00238.00192.00-
Short Term Receivables1,222.001,032.00875.00726.00721.00645.00713.00-
Inventories976.001,036.001,028.00628.00572.00616.00592.00-
Other Current Assets382.00404.00505.00403.00165.00155.00198.00-
Total Current Assets2,977.002,788.002,742.002,137.001,635.001,654.001,695.00-
Net Property, Plant & Equipment1,922.001,636.001,504.001,419.001,337.001,264.001,090.00-
Total Investments and Advances0.000.000.000.000.000.000.00-
Long-Term Note Receivable7.0019.0019.0012.00----
Intangible Assets8,039.008,017.008,164.006,565.006,850.007,247.007,409.00-
Deferred Tax Assets934.00885.00921.00927.00933.001,036.001,192.00-
Other Assets143.00124.0092.0084.0068.0065.0082.00-
Total Assets14,022.0013,469.0013,442.0011,144.0010,823.0011,266.0011,468.00-
Short Term Debt Incl. Current Port. of LT Debt77.0072.0057.0051.0020.0018.0016.00-
Accounts Payable388.00389.00522.00317.00239.00178.00262.00-
Income Tax Payable-----1.0038.00-
Other Current Liabilities1,455.001,277.001,000.00928.00840.00712.00719.00-
Total Current Liabilities1,920.001,738.001,579.001,296.001,099.00909.001,035.00-
Long Term Debt5,168.004,864.004,619.002,503.0092.0083.0077.00-
Provision for Risks Charges53.0056.0061.0063.0024.0027.0038.00-
Deferred Tax Liabilities19.0013.0014.007.00----
Other Liabilities343.00254.00249.00174.00206.00259.00286.00-
Total Liabilities7,503.006,925.006,522.004,043.001,421.001,278.001,436.00-
Non-Equity Reserves0.000.000.000.000.000.000.00-
Preferred Stock - Carrying Value0.000.000.000.000.000.000.00-
Common Equity6,448.006,473.006,850.007,033.009,329.009,918.009,959.00-
Total Shareholders Equity6,448.006,473.006,850.007,033.009,329.009,918.009,959.00-
Accumulated Minority Interest71.0071.0070.0068.0073.0070.0073.00-
Total Equity6,519.006,544.006,920.007,101.009,402.009,988.0010,032.00-
Total Liabilities & Stockholders Equity14,022.0013,469.0013,442.0011,144.0010,823.0011,266.0011,468.00-
Book Value Per Share18.2018.4519.5220.0926.65---
Tangible Book Value Per Share-4.49-4.40-3.741.347.08---
Full-Time Employees13,00013,50013,300-----
Price to Book Ratio1.190.960.880.810.81---
Return on Assets-2.62-2.36-2.120.051.65-0.16--
Return on Equity-5.57-4.76-3.750.071.89-0.18--
Return on Invested Capital-3.10-2.80-2.270.061.93-0.182.97-
Quick Ratio1.041.011.091.160.971.141.07-
Current Ratio1.551.601.741.651.491.821.64-

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-98.76-352.00-305.00-248.0015.00193.00-17.00303.00719.00
Depreciation396.77421.00436.00382.00379.00415.00442.00469.00495.00
Other Funds (Non Cash)278.57228.00198.00146.0060.00121.0059.00106.0071.00
Funds from Operations606.36265.00319.00270.00364.00845.00581.00839.00841.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-58.3718.00-87.00-287.00-19.0028.00-59.00-40.00-78.00
Cash from Operating Activities547.99283.00232.00-17.00345.00873.00522.00799.00763.00
Capital Expenditures-296.19-349.00-291.00-181.00-220.00-209.00-259.00-180.00-101.00
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses2.887.002.001.000.000.000.000.0027.00
Purchase or Sale of Investments-187.27-125.00-136.00-1,942.005.00-5.003.00-6.000.00
Purchase of Investments-198.10-133.00-150.00-1,958.00-17.00-19.00-6.00-16.00-7.00
Sale Or Maturity of Investments10.838.0014.0016.0022.0014.009.0010.007.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources8.7512.0013.0013.000.000.000.000.000.00
Cash from Investing Activities-471.84-455.00-412.00-2,109.00-215.00-214.00-256.00-186.00-74.00
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock1.980.000.000.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.000.00
Sale of Common Pref Stock1.980.000.000.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net144.19249.00201.002,099.002,424.000.000.000.000.00
Change in Long Term Debt144.19249.00201.002,099.002,424.000.000.000.000.00
Issuance of Long Term Debt2,993.253,345.00631.002,260.002,437.000.000.000.000.00
Reduction of Long Term Debt-2,849.06-3,096.00-430.00-161.00-13.000.000.000.000.00
Net Financing Active Other Cash Flow-39.29-24.00-23.00-21.00-2,343.00-712.00-232.00-606.00-665.00
Other Financing Activities Uses-39.29-24.00-23.00-21.00-2,374.00-740.00-232.00-606.00-665.00
Cash from Financing Activities106.88225.00178.002,078.0081.00-712.00-232.00-606.00-665.00
Exchange Rate Effect-1.3328.00-16.002.00-8.00-8.0012.00-3.00-8.00
Net Change in Cash181.7081.00-18.00-46.00203.00-61.0046.004.0016.00
Free Cash Flow251.80-66.00-59.00-198.00170.00680.00269.00619.00662.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow24.41---31.93----
Deferred Taxes & Investment Tax Credit--32.00-10.00-10.00-90.00116.0097.00-39.00-444.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments515.00378.00279.00397.00332.00272.00
Short Term Receivables1,147.001,161.001,106.001,222.001,094.001,088.00
Inventories1,007.00999.00977.00976.001,005.001,051.00
Other Current Assets386.00384.00414.00382.00424.00435.00
Total Current Assets3,055.002,922.002,776.002,977.002,855.002,846.00
Net Property, Plant & Equipment1,812.001,799.001,794.001,922.001,711.001,680.00
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets7,845.007,892.007,963.008,039.007,985.008,028.00
Deferred Tax Assets963.00952.00945.00934.00978.00973.00
Other Assets277.00287.00302.00143.00296.00298.00
Total Assets13,959.0013,859.0013,780.0014,022.0013,832.0013,832.00
Short Term Debt Incl. Current Port. of LT Debt45.0043.0039.0077.0028.0028.00
Accounts Payable367.00426.00407.00388.00395.00449.00
Other Current Liabilities1,548.001,421.001,374.001,455.001,473.001,363.00
Total Current Liabilities1,960.001,890.001,820.001,920.001,896.001,840.00
Long Term Debt5,050.005,072.005,031.005,168.004,922.004,931.00
Provision for Risks Charges0.000.000.0053.000.000.00
Deferred Tax Liabilities19.0018.0019.0019.0014.0014.00
Other Liabilities420.00435.00458.00343.00500.00539.00
Total Liabilities7,449.007,415.007,328.007,503.007,332.007,324.00
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity6,439.006,376.006,379.006,448.006,429.006,440.00
Total Shareholders Equity6,439.006,376.006,379.006,448.006,429.006,440.00
Accumulated Minority Interest71.0068.0073.0071.0071.0068.00
Total Equity6,510.006,444.006,452.006,519.006,500.006,508.00
Total Liabilities & Stockholders Equity13,959.0013,859.0013,780.0014,022.0013,832.0013,832.00
Book Value Per Share18.0217.8617.9018.2018.1618.20
Tangible Book Value Per Share-3.93-4.25-4.44-4.49-4.39-4.49
Full-Time Employees---13,000--
Price to Book Ratio1.190.930.870.940.830.72
Return on Assets-0.80-1.24-1.61-2.62-2.23-2.02
Return on Equity-1.73-2.67-3.44-5.57-4.69-4.22
Return on Invested Capital0.28-0.12-0.62-0.50-0.25-0.55
Quick Ratio1.041.020.991.040.980.98
Current Ratio1.561.551.531.551.511.55

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income35.10-9.63-70.00-54.22-24.77-62.74
Depreciation99.77101.06101.0094.94110.19110.75
Other Funds (Non Cash)60.6562.4359.0096.4821.0748.92
Funds from Operations192.74133.0178.00202.60101.62-13.67
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital36.7719.13-46.00-68.2737.4648.85
Cash from Operating Activities229.51152.1432.00134.34139.0835.18
Capital Expenditures-53.44-70.20-100.00-72.54-74.68-92.51
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses-0.02-0.013.00-0.097.110.00
Purchase or Sale of Investments-21.46-15.75-38.00-112.060.03-1.23
Purchase of Investments-25.39-19.73-39.00-113.99-0.97-2.32
Sale Or Maturity of Investments3.933.981.001.921.001.09
Other Uses0.000.000.000.000.000.00
Other Sources3.93-0.025.00-0.166.080.11
Cash from Investing Activities-70.99-85.99-130.00-184.86-61.47-93.63
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.01-0.012.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock-0.01-0.012.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-17.0948.79-3.00115.50-19.63113.66
Change in Long Term Debt-17.0948.79-3.00115.50-19.63113.66
Issuance of Long Term Debt26.9270.582,802.0093.75-19.503,227.78
Reduction of Long Term Debt-44.01-21.80-2,805.0021.75-0.13-3,114.12
Net Financing Active Other Cash Flow-4.75-14.84-19.00-0.707.18-21.53
Other Financing Activities Uses-4.75-14.84-19.00-0.707.18-21.53
Cash from Financing Activities-21.8533.93-20.00114.80-12.4692.13
Exchange Rate Effect-0.98-1.000.000.64-4.1322.55
Net Change in Cash135.6899.09-118.0064.9261.0256.22
Free Cash Flow176.0781.93-68.0061.8064.40-57.33
Price to Free Cash Flow24.4142.206,557.16---

Revenue breakdown

Branded and Other Generic Products2024: 281.00M 2025: 243.00M
Device Products2024: 1.80B 2025: 1.92B
Other Revenues2024: 17.00M 2025: 21.00M
Over the Counter Products2024: 1.72B 2025: 1.83B
Pharmaceutical Products2024: 969.00M 2025: 1.08B
Canada2024: 127.00M 2025: 135.00M
China2024: 358.00M 2025: 358.00M
France2024: 227.00M 2025: 246.00M
Germany2024: 152.00M 2025: 164.00M
Italy2024: 91.00M 2025: 102.00M
Japan2024: 180.00M 2025: 186.00M
Mexico2024: 75.00M 2025: 75.00M
Other Countries2024: 712.00M 2025: 777.00M
Poland2024: 65.00M 2025: 75.00M
Russia2024: 120.00M 2025: 148.00M
South Korea2024: 47.00M 2025: 51.00M
Spain2024: 92.00M 2025: 101.00M
United Kingdom2024: 132.00M 2025: 137.00M
United States and Puerto Rico2024: 2.41B 2025: 2.55B
Pharmaceuticals2024: 1.21B 2025: 1.28B
Surgical2024: 843.00M 2025: 894.00M
Vision Care2024: 2.74B 2025: 2.92B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-306.46%2.6M40.1M553.45K
2026-10-156.35%2.5M40.1M448.83K
2026-09-307.39%3.0M40.1M392.49K
2026-09-157.90%3.2M40.0M410.33K
2026-08-318.51%3.4M40.0M425.51K
2026-08-147.94%3.2M40.0M421.06K
2026-07-317.61%3.0M39.8M457.61K
2026-07-159.56%3.8M39.8M451.25K
2026-06-3010.02%4.0M39.8M451.74K
2026-06-1511.05%4.4M39.8M458.02K
2026-05-2910.75%4.1M37.8M445.62K
2026-05-156.50%2.5M38.5M473.45K
2026-04-309.35%3.6M38.6M442.85K
2026-04-159.88%3.7M37.6M408.29K
2026-03-319.52%3.6M37.9M418.05K
2026-03-1310.56%4.0M37.9M385.04K
2026-02-277.01%2.7M37.9M376.65K
2026-02-138.31%3.2M38.1M356.61K
2026-01-308.83%3.4M38.1M387.60K
2026-01-159.68%3.7M38.1M423.21K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call9.0010.0014.500.007.8700.000.000.978-0.0310.002
call10.009.0013.500.007.0900.000.000.975-0.0310.002
call11.008.0012.500.006.4070.000.000.972-0.0300.002
call12.008.0011.508.505.79436.000.000.969-0.0300.002
call13.006.0010.507.505.27511.000.000.964-0.0290.003
call14.005.009.505.904.76025.000.000.947-0.0380.004
call15.004.008.505.904.2721540.000.940-0.0360.004
call16.003.007.504.913.8222440.000.895-0.0560.006
call17.002.354.703.901.4734210.000.826-0.0890.009
call18.001.753.702.911.2101930.000.797-0.0820.009
call19.002.352.502.350.68738219.000.758-0.0740.010
call20.001.002.101.201.0361,4560.000.694-0.0640.012
call21.000.751.051.050.6551983.000.583-0.0510.013
call22.000.400.750.500.78082.0022.000.431-0.0620.013
call23.000.000.500.700.8321.000.000.308-0.0570.012
call24.000.001.350.001.2690.000.000.307-0.0830.012
call25.000.001.350.001.4620.000.000.279-0.0920.011
call26.000.001.350.001.6380.000.000.258-0.0990.011
call27.000.001.350.001.8030.000.000.242-0.1050.010
call28.000.001.350.001.9500.000.000.229-0.1100.010
call29.000.001.350.001.9830.000.000.202-0.1050.009
call30.000.001.350.002.1110.000.000.193-0.1080.009
put9.000.001.250.003.0990.000.00-0.022-0.0300.002
put10.000.004.600.002.7550.000.00-0.025-0.0300.002
put11.000.004.900.002.4460.000.00-0.028-0.0290.002
put12.000.004.900.002.1630.000.00-0.031-0.0280.002
put13.000.000.100.702.0592.000.00-0.046-0.0370.003
put14.000.004.900.271.8116.000.00-0.053-0.0360.004
put15.000.000.150.051.56389.000.00-0.061-0.0350.004
put16.000.000.300.051.6281401.00-0.104-0.0550.006
put17.000.000.750.051.80859.000.00-0.175-0.0860.009
put18.000.001.400.091.5274.000.00-0.202-0.0800.009
put19.000.001.000.401.21927.000.00-0.245-0.0710.010
put20.000.000.650.700.93775.000.00-0.304-0.0610.012
put21.000.300.751.050.69539.000.00-0.417-0.0480.013
put22.000.851.600.000.9270.000.00-0.566-0.0590.013
put23.001.352.350.000.9840.000.00-0.650-0.0700.012
put24.001.903.800.001.5760.000.00-0.692-0.0810.012
put25.002.355.100.002.0280.000.00-0.720-0.0890.011
put26.003.406.100.002.2230.000.00-0.741-0.0960.011
put27.003.508.000.003.1190.000.00-0.758-0.1020.010
put28.005.708.000.002.4840.000.00-0.771-0.1080.010
put29.006.409.000.002.6390.000.00-0.781-0.1120.010
put30.007.4010.100.002.8710.000.00-0.790-0.1170.010

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-03144Filing for proposed sale of securities under Rule 144.SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-10-29144Filing for proposed sale of securities under Rule 144.SEC
2026-10-2810-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-288-KCurrent report2026-10-28SEC
2026-10-288-KCurrent report2026-10-28SEC
2026-10-138-KCurrent report2026-10-11SEC
2026-09-28144Filing for proposed sale of securities under Rule 144.SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-143Initial statement of beneficial ownership of securities2026-08-05SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-143Initial statement of beneficial ownership of securities2026-08-05SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-143Initial statement of beneficial ownership of securities2026-08-05SEC
2026-08-143Initial statement of beneficial ownership of securities2026-08-05SEC
2026-08-124Statement of changes in beneficial ownership of securities2026-08-10SEC
2026-08-128-K/A2026-08-05SEC
2026-08-11144/ASEC
2026-08-10144Filing for proposed sale of securities under Rule 144.SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-07144Filing for proposed sale of securities under Rule 144.SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-08-05SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-10002.29M1
2026-090000
2026-08001.19M3
2026-070000
2026-060000
2026-050000
2026-040000
2026-03727.34K500
2026-02496.76K400
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
ICAHN CARL C0.98%
OAKTREE CAPITAL MANAGEMENT LP0.97%
DEUTSCHE BANK AG\0.93%
D. E. Shaw & Co., Inc.0.93%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP0.89%
GOLDENTREE ASSET MANAGEMENT LP0.75%
PRICE T ROWE ASSOCIATES INC /MD/0.61%
CASPIAN CAPITAL LP0.56%
GLENVIEW CAPITAL MANAGEMENT, LLC0.54%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0.38%

Funds

Fund% owned
Aristotle Floating Rate Income Fund16.87%
VANGUARD HIGH-YIELD CORPORATE FUND15.71%
BlackRock High Yield Portfolio12.50%
Fidelity Advisor Floating Rate High Income Fund10.25%
NYLIM MacKay High Yield Corporate Bond Fund7.85%
iShares Broad USD High Yield Corporate Bond ETF7.40%
Allspring Short-Term High Income Fund5.85%
LORD ABBETT BOND DEBENTURE FUND INC5.82%
PIMCO High Yield Fund5.70%
iShares iBoxx $ High Yield Corporate Bond ETF5.57%

OakChart. BLCO. Cached 15 minutes.